Related Experiment Video
Updated: Jul 3, 2025
06:53
3D Whole-heart Myocardial Tissue Analysis
Published on: April 12, 2017
8.8K
How artificial intelligence can assist with ischaemic heart disease
Jamol Uzokov1, Anis Alyavi1, Bakhromkhon Alyavi1,2
1Cardiology Department, Republican Specialized Scientific Practical Medical Center of Therapy and Medical Rehabilitation, 4 Osiyo, 100084 Tashkent, Uzbekistan.
European Heart Journal
|February 10, 2024
Abstract
No abstract available in PubMed .
Related Concept Videos
01:17Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431